Shanmuga Hospital Empanelled under Central Government Health Scheme (CGHS) for Three Years
Shanmuga Hospital Ltd has secured an agreement with the Central Government Health Scheme (CGHS), Ministry of Health & Family Welfare, Government of India. The empanelment confirms the hospital's commitment to providing quality healthcare services to a wide range of government beneficiaries.The Memorandum of Agreement (MoA) was executed on June 19, 2026, and is valid for a period of three years. This strategic collaboration positions Shanmuga Hospital as an authorized provider under the CGHS network.
Under the terms of the MoA, Shanmuga Hospital is now tasked with providing healthcare services to beneficiaries covered by the Central Government Health Scheme. This includes Central Government employees, pensioners, and other categories of beneficiaries designated by the Government of India at any given time.
The hospital's successful empanelment reflects its continued dedication to delivering high-quality medical care and is anticipated to enhance the accessibility of its facilities to eligible CGHS beneficiaries. The agreement falls within the ordinary course of business for the company.
Key details regarding this partnership are summarized in the table below:
| Particulars | Details |
|---|---|
| Partner Entity | Central Government Health Scheme (CGHS), Ministry of Health & Family Welfare, Government of India |
| Nature of Agreement | Memorandum of Agreement for empanelment under CGHS |
| Tenure | 3 Years from the date of Empanelment |
| Effective Date of Empanelment | June 19, 2026 |
| Purpose | To provide healthcare services to eligible CGHS beneficiaries as per the MoA terms and conditions. |
The empanelment is expected to broaden the hospital's patient base and strengthen its standing as a provider under this major government healthcare scheme.
Stock Price Movement
On Monday's close, Shanmuga Hospital Ltd shares dipped by 2.18%, settling at ₹34.53. The stock traded through its range on the day, achieving a high of ₹36.25 before finding its intraday low at ₹34.53.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.